We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
DxGen

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
23 Jan 2021 - 27 Jan 2021
Virtual Venue
24 Feb 2021 - 28 Feb 2021
Virtual Venue

Portable Blood Ammonia Detector Developed

By LabMedica International staff writers
Posted on 04 Aug 2020
Print article
Image: A prototype of the handheld ammonia blood detector and associated test strips (Photo courtesy of Thomas Veltman).
Image: A prototype of the handheld ammonia blood detector and associated test strips (Photo courtesy of Thomas Veltman).
Ammonia is a natural product of digestion that is usually processed into urea by the liver and passed out of the body in urine. Too much ammonia in the blood can cause mental and physical dysfunction and is a concern for people with liver disease or genetic conditions that hinder ammonia metabolism.

Effective treatments exist, but preventing permanent neurological sequelae requires rapid, accurate, and serial measurements of blood ammonia. Standard methods require volumes of 1 to 3 mL, centrifugation to isolate plasma, and a turn-around time of two hours. Collection, handling, and processing requirements mean that community clinics, particularly those in low resource settings, cannot provide reliable measurements.
New
Gold Supplier
COVID-19 Test
iAMP COVID-19 Detection Kit
New
COVID-19 and Influenza Test
COVID-19 and Influenza A+B Antigen Combo Rapid Test
Visit expo >

Biochemists at Stanford University (Stanford, CA, USA) developed a method to measure ammonia from small-volume whole blood samples in two minutes. The method alkalizes blood to release gas-phase ammonia for detection by a fuel cell. The device requires about one drop of blood, less than 1% of the blood for the standard test, and thus can be obtained with a small finger or earlobe prick. The device itself is about the size of a television remote and, as with a glucometer, the blood drops are dabbed onto a test strip that is inserted into one end.

While the sensor inside the device is very similar to existing ammonia sensors (used to detect toxic ammonia gas in industrial settings), the test strips are made from scratch. Blood applied to a small hole at one end of the strip zips through a microscopic channel and sinks into a paper-lined well at the opposite end, which is coated with an inexpensive chemical that liberates the ammonia from the sample. Inside the device, this well sits directly under the ammonia sensor. The device was tested on both adult and pediatric blood samples and showed a strong correlation with an academic clinical laboratory for plasma ammonia concentrations up to 500 μM (16 times higher than the upper limit of normal).

Natalia Gomez-Ospina, MD, PhD, an assistant professor of pediatrics and co-author of the paper, said, “I've spoken with families who have children with metabolic diseases about having this kind of device and it makes them emotional because, for them, the consequences of not getting ammonia checked accurately and quickly are so severe. For these families, it could be life-changing.” The study was published on June 15, 2020 in the journal ACS Sensors.

Related Links:
Stanford University


Print article

Channels

Molecular Diagnostics

view channel
Image: Histopathology of neurofibrillary tangles in the brain of a patient with Alzheimer`s disease (Bielschowski silver stain) (Photo courtesy of Dimitri P. Agamanolis, MD).

Alzheimer's Disease Subtypes Proposed from Brain Gene Expression Profiles

Alzheimer’s disease (AD) is the most common form of dementia in the elderly, estimated to affect more than 5.8 million individuals in the USA and more than 50 million worldwide, with almost half of individuals... Read more

Industry

view channel
Illustration

Thermo Fisher Acquires Point-of-Care Molecular Diagnostics Provider Mesa Biotech

Thermo Fisher Scientific Inc. (Waltham, MA, USA) has entered into a definitive agreement to acquire Mesa Biotech (San Diego, CA, USA), a privately held molecular diagnostic company, for approximately USD... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.